281 related articles for article (PubMed ID: 16605123)
1. Immunomodulation of pulmonary and hepatic granulomatous response in mice immunized with purified lung-stage schistosomulae antigen.
El-Ahwany EG; Nosseir MM; Aly IR
J Egypt Soc Parasitol; 2006 Apr; 36(1):335-50, following 350. PubMed ID: 16605123
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an antipathology vaccine in murine schistosomiasis administered with and without chemotherapy.
Botros SS; Doughty BL; Shaker ZA; Akl MM; Sharmy R; Diab TM; Hassanein HI
Int J Immunopharmacol; 1996 Dec; 18(12):707-18. PubMed ID: 9172014
[TBL] [Abstract][Full Text] [Related]
4. Immunization of mice with crude extract of Saccharomyces boulardii yeast induces cross-reactive immune responses with antigenic preparations from different developmental stages of the Schistosoma mansoni and reduces the parasite worm burden.
Bahgat M; Maghraby AS; Ab Del-Fatah OM; Elshafei AM
J Egypt Soc Parasitol; 2005 Aug; 35(2):563-80. PubMed ID: 16083068
[TBL] [Abstract][Full Text] [Related]
5. Excretory-secretory product of fasciola hepatica worm protects against Schistosoma mansoni infection in mice.
Hamed MA
Indian J Exp Biol; 2006 Jul; 44(7):554-61. PubMed ID: 16872044
[TBL] [Abstract][Full Text] [Related]
6. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
7. Application of adult worm and lung-stage antigens to immunize against Schistosoma mansoni using cytokines as adjuvants.
Afifi MA; El-Wakil HS; Abdel-Ghaffar MM; Mohamed RT
J Egypt Soc Parasitol; 2006 Apr; 36(1):351-62, 2p following 362. PubMed ID: 16605124
[TBL] [Abstract][Full Text] [Related]
8. The pharmacological approach to reverse portal hypertention and hepatic schistosomal fibrosis in Egypt, control experimental study.
Helmy AH; Abdel-Hady AA; el-Shanawany F; Hammam O; Abdel-Hady A
J Egypt Soc Parasitol; 2005 Dec; 35(3):731-50. PubMed ID: 16333884
[TBL] [Abstract][Full Text] [Related]
9. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
[TBL] [Abstract][Full Text] [Related]
10. T regulatory cell responses to immunization with a soluble egg antigen in Schistosoma mansoni-infected mice.
El-Ahwany E; Bauiomy IR; Nagy F; Zalat R; Mahmoud O; Zada S
Korean J Parasitol; 2012 Mar; 50(1):29-35. PubMed ID: 22451731
[TBL] [Abstract][Full Text] [Related]
11. An experimental study for evaluating the efficacy of cercarial vaccine against Schistosoma mansoni.
El-Marhoumy SM; El-Nouby KA; Emara MA; Abou Rayia DM
J Egypt Soc Parasitol; 2009 Dec; 39(3):917-32. PubMed ID: 20120755
[TBL] [Abstract][Full Text] [Related]
12. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
13. Immunization against Schistosoma mansoni by using Trichinella spiralis and Trichinella pseudospiralis antigens.
Youssef MM; Abu Samra LM; Hegazy IH
J Egypt Soc Parasitol; 1991 Aug; 21(2):309-18. PubMed ID: 1908495
[TBL] [Abstract][Full Text] [Related]
14. The Schistosoma mansoni egg-derived r38 peptide-induced Th1 response affects the synchronous pulmonary but not the asynchronous hepatic granuloma growth.
Chen Y; Boros DL
Parasite Immunol; 2001 Jan; 23(1):43-50. PubMed ID: 11136477
[TBL] [Abstract][Full Text] [Related]
15. Investigating Immunization With Nucleotide Enzymes of
Cagnazzo TDO; Nogueira CT; de Castro CA; Neris DM; Fattori ACM; Correia RO; Albuquerque YR; Fragelli BDL; Mendes TMF; Allegretti SM; Soares EG; Romanello L; Torini JR; Pereira HD; Anibal FF
Front Immunol; 2020; 11():569988. PubMed ID: 33072110
[TBL] [Abstract][Full Text] [Related]
16. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
Morsy GH
J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of protective immunity of 28KD-GST as a vaccine against experimental Schistosoma mansoni.
Hassan MM; Moustafa NE; El-Motayam MH; El-Settawy MA; Taha AA
J Egypt Soc Parasitol; 2009 Aug; 39(2):403-12. PubMed ID: 19795747
[TBL] [Abstract][Full Text] [Related]
18. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune responses induced in mice by purified iridoid mixture that inhibits penetration of Schistosoma mansoni cercariae upon topical treatment of mice tails.
Bahgat M; Shalaby NM; Ruppel A; Maghraby AS
J Egypt Soc Parasitol; 2005 Aug; 35(2):597-613. PubMed ID: 16083070
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccination using recombinant Schistosoma mansoni fatty acid binding protein (smFABP) gene.
Aly I; ELnain G; Hamad RS; Kilany M; Ghramh HA; Alshehri A; Dajem SM; Ibrahim EH
Exp Parasitol; 2018 Nov; 194():53-59. PubMed ID: 30266572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
